Annual CFO
$906.51 M
+$363.53 M+66.95%
31 December 2023
Summary:
IDEXX Laboratories annual cash flow from operations is currently $906.51 million, with the most recent change of +$363.53 million (+66.95%) on 31 December 2023. During the last 3 years, it has risen by +$258.45 million (+39.88%). IDXX annual CFO is now at all-time high.IDXX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$220.08 M
-$28.23 M-11.37%
30 September 2024
Summary:
IDEXX Laboratories quarterly cash flow from operations is currently $220.08 million, with the most recent change of -$28.23 million (-11.37%) on 30 September 2024. Over the past year, it has dropped by -$52.35 million (-19.22%). IDXX quarterly CFO is now -19.22% below its all-time high of $272.43 million, reached on 30 September 2023.IDXX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$916.83 M
-$52.35 M-5.40%
30 September 2024
Summary:
IDEXX Laboratories TTM cash flow from operations is currently $916.83 million, with the most recent change of -$52.35 million (-5.40%) on 30 September 2024. Over the past year, it has increased by +$86.74 million (+10.45%). IDXX TTM CFO is now -5.40% below its all-time high of $969.18 million, reached on 30 June 2024.IDXX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +67.0% | -19.2% | +10.4% |
| 3 y3 years | +39.9% | +17.6% | +19.9% |
| 5 y5 years | +126.6% | +66.4% | +108.7% |
IDXX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +67.0% | -19.2% | +234.2% | -5.4% | +68.8% |
| 5 y | 5 years | at high | +126.6% | -19.2% | +689.6% | -5.4% | +108.7% |
| alltime | all time | at high | >+9999.0% | -19.2% | +1602.9% | -5.4% | >+9999.0% |
IDEXX Laboratories Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $220.08 M(-11.4%) | $916.83 M(-5.4%) |
| June 2024 | - | $248.31 M(+25.0%) | $969.18 M(+5.2%) |
| Mar 2024 | - | $198.59 M(-20.5%) | $921.18 M(+1.6%) |
| Dec 2023 | $906.51 M(+66.9%) | $249.85 M(-8.3%) | $906.51 M(+9.2%) |
| Sept 2023 | - | $272.43 M(+36.0%) | $830.09 M(+11.2%) |
| June 2023 | - | $200.31 M(+8.9%) | $746.65 M(+22.0%) |
| Mar 2023 | - | $183.91 M(+6.0%) | $612.19 M(+12.7%) |
| Dec 2022 | $542.98 M(-28.1%) | $173.43 M(-8.2%) | $542.98 M(-6.3%) |
| Sept 2022 | - | $189.00 M(+187.0%) | $579.52 M(+0.3%) |
| June 2022 | - | $65.85 M(-42.6%) | $577.73 M(-22.5%) |
| Mar 2022 | - | $114.71 M(-45.4%) | $745.83 M(-1.3%) |
| Dec 2021 | $755.55 M(+16.6%) | $209.96 M(+12.2%) | $755.55 M(-1.2%) |
| Sept 2021 | - | $187.21 M(-20.0%) | $764.52 M(-0.8%) |
| June 2021 | - | $233.96 M(+88.0%) | $770.43 M(+3.5%) |
| Mar 2021 | - | $124.42 M(-43.2%) | $744.61 M(+14.9%) |
| Dec 2020 | $648.06 M(+41.1%) | $218.93 M(+13.4%) | $648.06 M(+10.9%) |
| Sept 2020 | - | $193.12 M(-7.2%) | $584.54 M(+11.6%) |
| June 2020 | - | $208.14 M(+646.8%) | $523.69 M(+15.7%) |
| Mar 2020 | - | $27.87 M(-82.1%) | $452.65 M(-1.4%) |
| Dec 2019 | $459.16 M(+14.8%) | $155.41 M(+17.5%) | $459.16 M(+4.5%) |
| Sept 2019 | - | $132.26 M(-3.5%) | $439.39 M(+5.2%) |
| June 2019 | - | $137.10 M(+298.8%) | $417.84 M(+4.6%) |
| Mar 2019 | - | $34.38 M(-74.7%) | $399.56 M(-0.1%) |
| Dec 2018 | $400.08 M(+7.2%) | $135.65 M(+22.5%) | $400.08 M(+3.8%) |
| Sept 2018 | - | $110.71 M(-6.8%) | $385.56 M(+0.0%) |
| June 2018 | - | $118.83 M(+240.5%) | $385.54 M(+2.3%) |
| Mar 2018 | - | $34.90 M(-71.2%) | $376.90 M(+1.0%) |
| Dec 2017 | $373.28 M(+10.1%) | $121.13 M(+9.4%) | $373.28 M(+5.8%) |
| Sept 2017 | - | $110.68 M(+0.4%) | $352.90 M(+3.0%) |
| June 2017 | - | $110.19 M(+252.3%) | $342.54 M(-0.2%) |
| Mar 2017 | - | $31.27 M(-69.0%) | $343.23 M(+1.3%) |
| Dec 2016 | $338.94 M(+52.8%) | $100.75 M(+0.4%) | $338.94 M(+6.7%) |
| Sept 2016 | - | $100.31 M(-9.5%) | $317.52 M(+7.9%) |
| June 2016 | - | $110.88 M(+310.8%) | $294.15 M(+11.7%) |
| Mar 2016 | - | $26.99 M(-66.0%) | $263.44 M(+18.8%) |
| Dec 2015 | $221.80 M(-6.0%) | $79.33 M(+3.1%) | $221.80 M(+30.6%) |
| Sept 2015 | - | $76.95 M(-4.0%) | $169.77 M(-8.8%) |
| June 2015 | - | $80.17 M(-647.4%) | $186.09 M(-0.9%) |
| Mar 2015 | - | -$14.64 M(-153.6%) | $187.68 M(-20.4%) |
| Dec 2014 | $235.85 M(-4.1%) | $27.30 M(-70.7%) | $235.85 M(-13.9%) |
| Sept 2014 | - | $93.26 M(+14.1%) | $273.96 M(+5.9%) |
| June 2014 | - | $81.76 M(+143.9%) | $258.79 M(+0.1%) |
| Mar 2014 | - | $33.52 M(-48.8%) | $258.46 M(+5.1%) |
| Dec 2013 | $246.00 M(+10.6%) | $65.42 M(-16.2%) | $246.00 M(-1.4%) |
| Sept 2013 | - | $78.10 M(-4.1%) | $249.50 M(+1.4%) |
| June 2013 | - | $81.43 M(+286.7%) | $246.09 M(+7.8%) |
| Mar 2013 | - | $21.05 M(-69.5%) | $228.28 M(+2.6%) |
| Dec 2012 | $222.41 M(+2.1%) | $68.92 M(-7.7%) | $222.41 M(+7.0%) |
| Sept 2012 | - | $74.69 M(+17.4%) | $207.88 M(-0.2%) |
| June 2012 | - | $63.62 M(+319.0%) | $208.40 M(+0.3%) |
| Mar 2012 | - | $15.18 M(-72.1%) | $207.88 M(-4.6%) |
| Dec 2011 | $217.91 M(+21.9%) | $54.40 M(-27.7%) | $217.91 M(+2.6%) |
| Sept 2011 | - | $75.21 M(+19.2%) | $212.37 M(+10.6%) |
| June 2011 | - | $63.09 M(+150.2%) | $192.06 M(+3.9%) |
| Mar 2011 | - | $25.22 M(-48.4%) | $184.85 M(+3.4%) |
| Dec 2010 | $178.83 M(+2.2%) | $48.85 M(-11.0%) | $178.83 M(-5.6%) |
| Sept 2010 | - | $54.90 M(-1.8%) | $189.43 M(+5.7%) |
| June 2010 | - | $55.88 M(+191.0%) | $179.16 M(-1.3%) |
| Mar 2010 | - | $19.20 M(-67.7%) | $181.53 M(+3.8%) |
| Dec 2009 | $174.95 M(+22.1%) | $59.45 M(+33.2%) | $174.95 M(+17.4%) |
| Sept 2009 | - | $44.62 M(-23.4%) | $149.00 M(+2.0%) |
| June 2009 | - | $58.26 M(+361.5%) | $146.05 M(-8.0%) |
| Mar 2009 | - | $12.62 M(-62.3%) | $158.72 M(+10.8%) |
| Dec 2008 | $143.31 M | $33.49 M(-19.6%) | $143.31 M(-4.3%) |
| Sept 2008 | - | $41.67 M(-41.2%) | $149.75 M(+6.9%) |
| June 2008 | - | $70.93 M(-2643.2%) | $140.13 M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$2.79 M(-107.0%) | $133.72 M(-1.0%) |
| Dec 2007 | $135.12 M(+23.0%) | $39.93 M(+24.6%) | $135.12 M(+1.1%) |
| Sept 2007 | - | $32.06 M(-50.3%) | $133.61 M(+4.2%) |
| June 2007 | - | $64.52 M(-4752.0%) | $128.17 M(+15.0%) |
| Mar 2007 | - | -$1.39 M(-103.6%) | $111.46 M(+1.5%) |
| Dec 2006 | $109.83 M(-5.8%) | $38.41 M(+44.3%) | $109.83 M(-1.5%) |
| Sept 2006 | - | $26.62 M(-44.3%) | $111.46 M(-9.6%) |
| June 2006 | - | $47.81 M(-1681.6%) | $123.25 M(+8.8%) |
| Mar 2006 | - | -$3.02 M(-107.5%) | $113.25 M(-2.8%) |
| Dec 2005 | $116.55 M(+22.2%) | $40.05 M(+4.2%) | $116.55 M(+12.4%) |
| Sept 2005 | - | $38.42 M(+1.6%) | $103.68 M(+15.8%) |
| June 2005 | - | $37.80 M(>+9900.0%) | $89.57 M(+5.4%) |
| Mar 2005 | - | $282.00 K(-99.0%) | $84.99 M(-10.9%) |
| Dec 2004 | $95.38 M(-18.6%) | $27.17 M(+11.8%) | $95.38 M(+1.9%) |
| Sept 2004 | - | $24.31 M(-26.8%) | $93.61 M(-1.9%) |
| June 2004 | - | $33.23 M(+211.5%) | $95.46 M(-2.9%) |
| Mar 2004 | - | $10.67 M(-58.0%) | $98.28 M(-16.1%) |
| Dec 2003 | $117.16 M(+13.5%) | $25.40 M(-2.9%) | $117.16 M(+15.9%) |
| Sept 2003 | - | $26.17 M(-27.4%) | $101.08 M(-12.2%) |
| June 2003 | - | $36.05 M(+22.0%) | $115.08 M(+6.2%) |
| Mar 2003 | - | $29.54 M(+216.8%) | $108.34 M(+4.9%) |
| Dec 2002 | $103.25 M(+122.7%) | $9.33 M(-76.8%) | $103.25 M(-5.9%) |
| Sept 2002 | - | $40.16 M(+37.1%) | $109.68 M(+19.5%) |
| June 2002 | - | $29.31 M(+19.8%) | $91.76 M(+18.0%) |
| Mar 2002 | - | $24.45 M(+55.2%) | $77.78 M(+67.8%) |
| Dec 2001 | $46.36 M(+64.2%) | $15.76 M(-29.2%) | $46.36 M(+16.5%) |
| Sept 2001 | - | $22.25 M(+45.2%) | $39.81 M(+45.9%) |
| June 2001 | - | $15.32 M(-320.2%) | $27.30 M(+27.3%) |
| Mar 2001 | - | -$6.96 M(-175.6%) | $21.44 M(-24.1%) |
| Dec 2000 | $28.24 M(-46.3%) | $9.21 M(-5.4%) | $28.24 M(-27.1%) |
| Sept 2000 | - | $9.73 M(+2.7%) | $38.73 M(-2.2%) |
| June 2000 | - | $9.47 M(-5945.1%) | $39.61 M(-26.8%) |
| Mar 2000 | - | -$162.00 K(-100.8%) | $54.14 M(+2.9%) |
| Dec 1999 | $52.60 M(+14.1%) | $19.70 M(+85.8%) | $52.60 M(+40.3%) |
| Sept 1999 | - | $10.60 M(-55.8%) | $37.50 M(-7.4%) |
| June 1999 | - | $24.00 M(-1511.8%) | $40.50 M(+13.4%) |
| Mar 1999 | - | -$1.70 M(-137.0%) | $35.70 M(-22.6%) |
| Dec 1998 | $46.10 M(+241.5%) | $4.60 M(-66.2%) | $46.10 M(+2.2%) |
| Sept 1998 | - | $13.60 M(-29.2%) | $45.10 M(+34.6%) |
| June 1998 | - | $19.20 M(+120.7%) | $33.50 M(+34.0%) |
| Mar 1998 | - | $8.70 M(+141.7%) | $25.00 M(+85.2%) |
| Dec 1997 | $13.50 M(+68.8%) | $3.60 M(+80.0%) | $13.50 M(-0.7%) |
| Sept 1997 | - | $2.00 M(-81.3%) | $13.60 M(+23.6%) |
| June 1997 | - | $10.70 M(-482.1%) | $11.00 M(0.0%) |
| Mar 1997 | - | -$2.80 M(-175.7%) | $11.00 M(+37.5%) |
| Dec 1996 | $8.00 M(+17.6%) | $3.70 M(-716.7%) | $8.00 M(+1500.0%) |
| Sept 1996 | - | -$600.00 K(-105.6%) | $500.00 K(-92.5%) |
| June 1996 | - | $10.70 M(-284.5%) | $6.70 M(-242.6%) |
| Mar 1996 | - | -$5.80 M(+52.6%) | -$4.70 M(-169.1%) |
| Dec 1995 | $6.80 M(-54.1%) | -$3.80 M(-167.9%) | $6.80 M(-48.1%) |
| Sept 1995 | - | $5.60 M(-900.0%) | $13.10 M(+12.9%) |
| June 1995 | - | -$700.00 K(-112.3%) | $11.60 M(-37.0%) |
| Mar 1995 | - | $5.70 M(+128.0%) | $18.40 M(+24.3%) |
| Dec 1994 | $14.80 M(+100.0%) | $2.50 M(-39.0%) | $14.80 M(+7.2%) |
| Sept 1994 | - | $4.10 M(-32.8%) | $13.80 M(+26.6%) |
| June 1994 | - | $6.10 M(+190.5%) | $10.90 M(+45.3%) |
| Mar 1994 | - | $2.10 M(+40.0%) | $7.50 M(+1.4%) |
| Dec 1993 | $7.40 M(-7500.0%) | $1.50 M(+25.0%) | $7.40 M(+10.4%) |
| Sept 1993 | - | $1.20 M(-55.6%) | $6.70 M(+8.1%) |
| June 1993 | - | $2.70 M(+35.0%) | $6.20 M(+181.8%) |
| Mar 1993 | - | $2.00 M(+150.0%) | $2.20 M(-2300.0%) |
| Dec 1992 | -$100.00 K(-102.6%) | $800.00 K(+14.3%) | -$100.00 K(-88.9%) |
| Sept 1992 | - | $700.00 K(-153.8%) | -$900.00 K(-43.8%) |
| June 1992 | - | -$1.30 M(+333.3%) | -$1.60 M(+433.3%) |
| Mar 1992 | - | -$300.00 K | -$300.00 K |
| Dec 1991 | $3.80 M | - | - |
FAQ
- What is IDEXX Laboratories annual cash flow from operations?
- What is the all time high annual CFO for IDEXX Laboratories?
- What is IDEXX Laboratories annual CFO year-on-year change?
- What is IDEXX Laboratories quarterly cash flow from operations?
- What is the all time high quarterly CFO for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly CFO year-on-year change?
- What is IDEXX Laboratories TTM cash flow from operations?
- What is the all time high TTM CFO for IDEXX Laboratories?
- What is IDEXX Laboratories TTM CFO year-on-year change?
What is IDEXX Laboratories annual cash flow from operations?
The current annual CFO of IDXX is $906.51 M
What is the all time high annual CFO for IDEXX Laboratories?
IDEXX Laboratories all-time high annual cash flow from operations is $906.51 M
What is IDEXX Laboratories annual CFO year-on-year change?
Over the past year, IDXX annual cash flow from operations has changed by +$363.53 M (+66.95%)
What is IDEXX Laboratories quarterly cash flow from operations?
The current quarterly CFO of IDXX is $220.08 M
What is the all time high quarterly CFO for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly cash flow from operations is $272.43 M
What is IDEXX Laboratories quarterly CFO year-on-year change?
Over the past year, IDXX quarterly cash flow from operations has changed by -$52.35 M (-19.22%)
What is IDEXX Laboratories TTM cash flow from operations?
The current TTM CFO of IDXX is $916.83 M
What is the all time high TTM CFO for IDEXX Laboratories?
IDEXX Laboratories all-time high TTM cash flow from operations is $969.18 M
What is IDEXX Laboratories TTM CFO year-on-year change?
Over the past year, IDXX TTM cash flow from operations has changed by +$86.74 M (+10.45%)